News Tonight AfricaFDA Panel Rejects OTC allergy drug SingulairNews Tonight AfricaThe U.S. FDA panel has rejected Merck’s application for approval of its prescription drug Singulair as over the counter medication. The FDA panel voted 11-4 against the asthma and allergies drug Singulair. Singulair has been a blockbuster drug for Merck for …FDA Panel Says No to Over-the-Counter Allergy Drug SingulairU.S. News & World ReportFDA Panel Rejects OTC Use of Montelukast (Singulair Allergy)MedscapeFDA Panel Nixes OTC SingulairMedPage TodayKPVI News 6all 16 news articles …Read Full Story
FDA Panel Rejects OTC allergy drug Singulair - News Tonight Africa
Real Estate of Cebu
